Harm Reduction Intervention for Anabolic-androgenic Steroids Users: a Randomized Controlled Trial

Starting soon · Not applicable

Conditions studied: Drug Abuse, Harm Reduction, Minimization, Harm, Anabolic Steroids Adverse Events, Brief Intervention

In brief

This clinical trial aims to investigate the short and long-term efficacy of a harm reduction intervention in reducing the use of non-clinical anabolic-androgenic steroids (AAS) in abusive users of AAS. As secondary objectives, the study will investigate the intervention's effect on health parameters (i.e., blood), quality of life, sleep quality, body image, eating behavior, depression, anxiety, fatigue, aggressiveness, cardiovascular parameters, muscle strength, body composition and muscle cross-sectional area outcomes.

Key facts

Study ID

NCT07039539

Run by

University of Sao Paulo

People needed

32

Starts

2026-08-01

Expected to finish

2028-01-30

Last updated by the study team

2026-07-16

Who can join

Age: 15 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Anyone over 15 years of age;
• Planning to use/increase the dose of AAS for aesthetic and/or physical performance purposes;
• Plan to use/increase the dose of AAS during eight to twelve weeks.

You may not qualify if…

• Medical prescription for AAS use;
• Use for sexual reassignment.

Where it is running

• Clinical Hospital of the School of Medicine, University of Sao Paulo — São Paulo, São Paulo, Brazil

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.